NYSE - Nasdaq Real Time Price • USD
DaVita Inc. (DVA)
At close: April 18 at 4:00 PM EDT
Pre-Market: 4:10 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | 1.95 | 2.5 | 9.01 | 10.08 |
| Low Estimate | 1.86 | 2.37 | 7.65 | 8.86 |
| High Estimate | 2.07 | 2.79 | 9.4 | 11.12 |
| Year Ago EPS | 1.25 | 1.91 | 7.42 | 9.01 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 3.03B | 3.14B | 12.59B | 13.08B |
| Low Estimate | 2.98B | 3.11B | 12.48B | 12.97B |
| High Estimate | 3.06B | 3.18B | 12.73B | 13.23B |
| Year Ago Sales | 2.87B | 2.95B | 12.14B | 12.59B |
| Sales Growth (year/est) | 5.40% | 6.30% | 3.70% | 3.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.14 | 1.69 | 2.02 | 1.59 |
| EPS Actual | 1.25 | 1.91 | 2.62 | 1.62 |
| Difference | 0.11 | 0.22 | 0.6 | 0.03 |
| Surprise % | 9.60% | 13.00% | 29.70% | 1.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.95 | 2.5 | 9.01 | 10.08 |
| 7 Days Ago | 1.92 | 2.49 | 8.94 | 10.08 |
| 30 Days Ago | 1.92 | 2.49 | 8.94 | 10.08 |
| 60 Days Ago | 1.95 | 2.53 | 8.94 | 10.09 |
| 90 Days Ago | 1.67 | 2.37 | 8.68 | 10.65 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 1 |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | DVA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 56.00% | -- | -- | 0.80% |
| Next Qtr. | 30.90% | -- | -- | 9.60% |
| Current Year | 21.40% | -- | -- | 4.50% |
| Next Year | 11.90% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 4.84% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Initiated | Barclays: Equal-Weight | 3/6/2024 |
| Maintains | Truist Securities: Hold to Hold | 2/20/2024 |
| Maintains | UBS: Buy to Buy | 2/15/2024 |
| Maintains | UBS: Buy to Buy | 2/14/2024 |
| Maintains | Truist Securities: Hold to Hold | 2/14/2024 |
| Maintains | UBS: Buy to Buy | 11/17/2023 |
Related Tickers
HCA HCA Healthcare, Inc.
297.00
-4.51%
FMS Fresenius Medical Care AG
19.39
+2.21%
UHS Universal Health Services, Inc.
153.65
-3.99%
THC Tenet Healthcare Corporation
91.08
-5.12%
ADUS Addus HomeCare Corporation
97.16
+0.56%
ENSG The Ensign Group, Inc.
116.48
-1.14%
EHC Encompass Health Corporation
78.62
-1.34%
CHE Chemed Corporation
597.42
-1.12%
PACS PACS Group, Inc.
23.00
-1.71%
BKD Brookdale Senior Living Inc.
6.52
+0.93%